PROTECT Data and Teplizumab in Newly Diagnosed T1D
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

PROTECT Data and Teplizumab in Newly Diagnosed T1D

2023-10-25
In this episode, hosts discuss data from the PROTECT trial, which examined the effects of teplizumab on beta-cell function in patients with newly diagnosed type 1 diabetes.
Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free